Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Replenix Power of Three Cream With Resveratrol for Facial Acne Vulgaris
NCT03563365Phase 4Terminated
- Sponsor
- Yardley Dermatology Associates
- Start
- Jun 2018
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Replenix Power of 3 Cream in acne vulgaris, sponsored by Yardley Dermatology Associates. Started Jun 2018; status: terminated.
02
Drugs
Replenix Power of 3 Cream
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT03563365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03563365.